Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ophthalmic Plast Reconstr Surg ; 36(6): e144-e147, 2020.
Article in English | MEDLINE | ID: mdl-32282640

ABSTRACT

An 85-year-old man presented with a 6-month history of worsening left proptosis and painless ophthalmoplegia. Imaging revealed an extensive intraconal and extraconal tumor extending to the level of the optic foramen, as well as the scalp, cheek, and the nasal bridge. Incisional biopsy was consistent with lacrimal gland adenocarcinoma. The patient underwent a left orbital exenteration followed by immunotherapy with pembrolizumab. The treatment was stopped prematurely after 5 cycles due to development of autoimmune colitis. Four months later, the patient developed new contralateral disease in the right orbit and an incisional biopsy again showed lacrimal gland adenocarcinoma. Following the incisional biopsy, no further treatment was administered, but over the ensuing 6 months, there was dramatic spontaneous regression of the tumor both clinically and radiographically. At 28 months, the patient is still alive with relatively stable disease.


Subject(s)
Adenocarcinoma , Eye Neoplasms , Lacrimal Apparatus Diseases , Lacrimal Apparatus , Adenocarcinoma/drug therapy , Aged, 80 and over , Antibodies, Monoclonal, Humanized , Humans , Lacrimal Apparatus Diseases/diagnosis , Lacrimal Apparatus Diseases/drug therapy , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...